Fig. 1From: Biodistribution and post-therapy dosimetric analysis of [177Lu]Lu-DOTAZOL in patients with osteoblastic metastases: first resultsPlanar scintigraphy (anterior and posterior views) after therapeutic application of [177Lu]Lu-DOTAZOL at a 20 min, b 3 h, c 24 h, d 168 h, and e PET/CT after application of [68Ga]Ga-DOTAZOL in a patient with bone metastases secondary to bronchial carcinoma (patient no. 3)Back to article page